Scrip Citeline Commercial: What Does 2024 Hold For Biopharma?

Josh Ludwig joins industry experts in discussing what 2024 has in store for the biopharma industry, including improvements for delivery of cell and gene therapies, a focus by contract manufacturers and developers on sustainability and continued emphasis on access to critical drugs.